We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Industry Plans to Lobby Administration to Fund Critical Path in 2007
Industry Plans to Lobby Administration to Fund Critical Path in 2007
January 6, 2006
The biotechnology industry is planning to lobby the Bush administration to fund the FDA’s Critical Path Initiative because of concerns that delays in the program could hinder industry’s efforts to develop personalized medicines, a high-ranking industry official says.